What is AAIC®?
The Alzheimer's Association International Conference® (AAIC®) is the world's largest conference of its kind, bringing together researchers from around the world to report and discuss groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer's disease and related disorders. As a part of the Alzheimer's Association's research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.
As the world's largest gathering of Alzheimer's disease researchers, AAIC:
- Brings together thousands of leaders from all over the world;
- Generates thousands of abstract submissions and scientific sessions; and
- Ultimately reaches millions of people with Alzheimer's research discoveries through print, radio and television news coverage.
Save the date for AAIC 2015:
Washington, D.C., United States, July 18-23, 2015
Knowledge sharing to advance research
As a part of the Alzheimer's Association research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community. The information shared at AAIC forms the foundation for Alzheimer's advances. By encouraging the attendance of researchers from around the world, the Alzheimer's Association is able to bring new innovations in Alzheimer's research to a single thought forum designed to accelerate the understanding of Alzheimer's and related dementias.
New discoveries presented at AAIC
AAIC provides a platform for presentation and discussion of all aspects of Alzheimer's research from genetics to animal models, pathology, biomarkers, interventions, and social and behavioral issues.
After each conference, the Alzheimer's Association develops and shares an "AAIC wrap up report," highlighting the key discoveries presented at the conference.
Compelling science news presented at past AAICs includes:
- Expanding understanding of the earliest stages of Alzheimer's disease. Subjective cognitive decline (SCD) may be a risk factor for mild cognitive impairment and later, Alzheimer's disease, according to results of observational studies. An international workgroup has formed and set a research agenda to study SCD. (AAIC 2013)
- Results of "Alzheimer's Vaccine" trials (AAICAD 1999 and AAICAD 2008)
- Successful small human studies with the Pittsburgh compound B (PIB) to show beta-amyloid in the brain using imaging technology (AAICAD 2002)
- Findings on the connection between Type 2 diabetes and an increased risk for Alzheimer's (AAICAD 2007)
Back to top
Sign up for our weekly e-newsletter
Be the first to know about discoveries made at AAIC. Sign up for our weekly enews, plus receive the latest info on advances in Alzheimer's treatments, care and research. Subscribe now
Our leadership role
The first assembly of what has become the world's largest and most prestigious international Alzheimer's research conference took place in Las Vegas, Nevada, in 1988 with some 300 researchers in attendance.
In 2000, the Alzheimer's Association assumed organizing and managing AAIC. Under our leadership, AAIC has increased:
- Attendance: Broadened outreach efforts to the scientific community increase attendance each year. In fact, AAICAD 2008 broke attendance records, drawing more than 5,400 participants and prompting a move to an annual format.
- Abstract submissions and scientific presentations: The prestige of presenting at AAIC generates thousands of abstract submissions, and AAIC now hosts more than 2,000 scientific sessions, representing the single largest sharing of research about Alzheimer's and dementia.
- Program quality: Efforts to get the broader Alzheimer's disease field engaged in AAIC's program planning process, including international researchers, has ensured we are delivering a conference that meets the diverse needs of the field.
- Conference frequency: In 2009, AAIC became an annual event to keep momentum within the field, expand opportunities for collaborations among scientists, and speed the sharing of information that is essential to research advances.
- Public awareness and media coverage: Our media relations efforts bring the latest research discoveries to millions of individuals through television, print, online and radio. AAIC news has received coverage from ABC, the BBC, CBS, CNN, NBC, the Associated Press, Reuters, Good Morning America, The Wall Street Journal, The Washington Post, USA Today, WebMD.com and Forbes.com.
To learn more about the current AAIC, how to submit an abstract, or details about attending, please visit the AAIC website.
Next: Professional Society »